Application of an ex-vivo drug sensitivity platform towards achieving complete remission in a refractory T-cell lymphoma.
Blood Cancer J
; 10(1): 9, 2020 01 27.
Article
in En
| MEDLINE
| ID: mdl-31988286
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Remission Induction
/
Lymphoma, T-Cell
Type of study:
Diagnostic_studies
Limits:
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Blood Cancer J
Year:
2020
Type:
Article
Affiliation country:
Singapore